Stay updated with breaking news from Multiple Sclerosis Impact Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MSHigh-dose frexalimab significantly reduced dis...
In an observational cohort study, factors such as education, income, and marital status correlated with MS severity outcomes.
Current smoking and passive smoking exposure may accelerate disease progression in MS, which suggests smoking cessation may slow disability worsening.
Current smoking and passive smoking exposure may accelerate disease progression in MS, which suggests smoking cessation may slow disability worsening.
Early DMT initiation is associated with improved physical and psychological outcomes, but not overall quality of life, in patients with MS.